Zenas BioPharma, Inc. stock forecast
Want to see ZBIO full AI Analyst Report?
Zenas BioPharma, Inc. (ZBIO) Stock Forecast & Price Target
ZBIO Analyst Ratings
ZBIO Stock 12 Month Forecast
Average Price Target
$44.80▲(56.10% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Matthew Caufield | H.C. Wainwright | $44 | buy | 53.31%Upside | Reiterated | 11/09/26 | ||
 Unknown AnalystNot Ranked | Wedbush | $45 | buy | 56.79%Upside | Reiterated | 11/06/26 | ||
| Chris YuNot Ranked | Morgan Stanley | $32 | hold | 11.50%Upside | Reiterated | 11/06/26 | ||
| Unknown AnalystNot Ranked | Guggenheim | $55 | buy | 91.64%Upside | Reiterated | 11/06/26 | ||
| Yigal Nochomovitz | Citi | $48 | buy | 67.25%Upside | Reiterated | 10/27/26 | ||
| Cory Kasimov | Evercore ISI | $55 | buy | 91.64%Upside | Reiterated | 03/17/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Matthew CaufieldH.C. Wainwright | BuyReiterated$44 | 11/09/26 | 53.31%Upside | ||
| Unknown AnalystWedbushNot Ranked | BuyReiterated$45 | 11/06/26 | 56.79%Upside | ||
| Chris YuMorgan StanleyNot Ranked | HoldReiterated$32 | 11/06/26 | 11.50%Upside | ||
| Unknown AnalystGuggenheimNot Ranked | BuyReiterated$55 | 11/06/26 | 91.64%Upside | ||
| Yigal NochomovitzCiti | BuyReiterated$48 | 10/27/26 | 67.25%Upside | ||
| Cory KasimovEvercore ISI | BuyReiterated$55 | 03/17/26 | 91.64%Upside |
Best Analysts Covering Zenas BioPharma, Inc.
Copying Matthew Caufield's trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +16.39% per trade.
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +57.09% per trade.
Copying Matthew Caufield's trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +59.77% per trade.
ZBIO Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 4 | 11 | 12 |
| Buy | 0 | 1 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 8 | 8 | 8 | 16 | 16 |
In the current month, ZBIO has received 14 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ZBIO average Analyst price target in the past 3 months is 44.80.
ZBIO Financial Forecast
ZBIO Earnings Forecast
Next quarter’s earnings estimate for ZBIO is -$1.17 with a range of -$1.39 to -$0.53. The previous quarter’s EPS was -$1.65. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ZBIO Sales Forecast
Next quarter’s sales forecast for ZBIO is $11.26M with a range of $0 to $56.30M. The previous quarter’s sales results were $10.00M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
